Literature DB >> 29705186

Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury.

John G Cooper1, Su Ji Jeong1, Tammy L McGuire1, Sripadh Sharma1, Wenxia Wang2, Swati Bhattacharyya2, John Varga2, John A Kessler3.   

Abstract

Gliosis and fibrosis after spinal cord injury (SCI) lead to formation of a scar that is an impediment to axonal regeneration. Fibrotic scarring is characterized by the accumulation of fibronectin, collagen, and fibroblasts at the lesion site. The mechanisms regulating fibrotic scarring after SCI and its effects on axonal elongation and functional recovery are not well understood. In this study, we examined the effects of eliminating an isoform of fibronectin containing the Extra Domain A domain (FnEDA) on both fibrosis and on functional recovery after contusion SCI using male and female FnEDA-null mice. Eliminating FnEDA did not reduce the acute fibrotic response but markedly diminished chronic fibrotic scarring after SCI. Glial scarring was unchanged after SCI in FnEDA-null mice. We found that FnEDA was important for the long-term stability of the assembled fibronectin matrix during both the subacute and chronic phases of SCI. Motor functional recovery was significantly improved, and there were increased numbers of axons in the lesion site compared to wildtype mice, suggesting that the chronic fibrotic response is detrimental to recovery. Our data provide insight into the mechanisms of fibrosis after SCI and suggest that disruption of fibronectin matrix stability by targeting FnEDA represents a potential therapeutic strategy for promoting recovery after SCI.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibronectin; Fibronectin EDA; Fibrosis; Gliosis; Matrix; Scarring; Spinal cord injury

Mesh:

Substances:

Year:  2018        PMID: 29705186      PMCID: PMC5995671          DOI: 10.1016/j.nbd.2018.04.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  47 in total

1.  Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction.

Authors:  K Shiozawa; K Hino; S Shiozawa
Journal:  Rheumatology (Oxford)       Date:  2001-07       Impact factor: 7.580

2.  Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Authors:  Su Ji Jeong; John G Cooper; Igal Ifergan; Tammy L McGuire; Dan Xu; Zoe Hunter; Sripadh Sharma; Derrick McCarthy; Stephen D Miller; John A Kessler
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

3.  Optimization of a mouse locomotor rating system to evaluate compression-induced spinal cord injury: correlation of locomotor and morphological injury indices.

Authors:  Yuesheng Li; Rod J Oskouian; Yuan-Ji Day; John A Kern; Joel Linden
Journal:  J Neurosurg Spine       Date:  2006-02

4.  2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region.

Authors:  D J Leahy; I Aukhil; H P Erickson
Journal:  Cell       Date:  1996-01-12       Impact factor: 41.582

5.  Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma.

Authors:  Swati Bhattacharyya; Kathleen Kelley; Denisa S Melichian; Zenshiro Tamaki; Feng Fang; Yunyun Su; Gilbert Feng; Richard M Pope; G R Scott Budinger; Gökhan M Mutlu; Robert Lafyatis; Timothy Radstake; Carol Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2012-11-07       Impact factor: 4.307

6.  Fibronectin Matrix Assembly after Spinal Cord Injury.

Authors:  Yunjiao Zhu; Cynthia Soderblom; Michelle Trojanowsky; Do-Hun Lee; Jae K Lee
Journal:  J Neurotrauma       Date:  2015-03-09       Impact factor: 5.269

7.  An essential role for fibronectin extra type III domain A in pulmonary fibrosis.

Authors:  Andrés F Muro; Federico A Moretti; Bethany B Moore; Mei Yan; Rachelle G Atrasz; Carol A Wilke; Kevin R Flaherty; Fernando J Martinez; Jessica L Tsui; Dean Sheppard; Francisco E Baralle; Galen B Toews; Eric S White
Journal:  Am J Respir Crit Care Med       Date:  2007-12-20       Impact factor: 21.405

8.  Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments.

Authors:  Vance P Lemmon; Adam R Ferguson; Phillip G Popovich; Xiao-Ming Xu; Diane M Snow; Michihiro Igarashi; Christine E Beattie; John L Bixby
Journal:  J Neurotrauma       Date:  2014-07-11       Impact factor: 5.269

9.  Models of fibronectin.

Authors:  M Rocco; E Infusini; M G Daga; L Gogioso; C Cuniberti
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

10.  Fibronectin molecule visualized in electron microscopy: a long, thin, flexible strand.

Authors:  H P Erickson; N Carrell; J McDonagh
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  14 in total

Review 1.  The influence of microenvironment and extracellular matrix molecules in driving neural stem cell fate within biomaterials.

Authors:  Thomas Wilems; Sangamithra Vardhan; Siliang Wu; Shelly Sakiyama-Elbert
Journal:  Brain Res Bull       Date:  2019-03-18       Impact factor: 4.077

2.  Spinal Cord Injury Results in Chronic Mechanical Stiffening.

Authors:  John G Cooper; Delphine Sicard; Sripadh Sharma; Stephanie Van Gulden; Tammy L McGuire; Miguel Pareja Cajiao; Daniel J Tschumperlin; John A Kessler
Journal:  J Neurotrauma       Date:  2019-10-18       Impact factor: 5.269

Review 3.  The fibrogenic niche in kidney fibrosis: components and mechanisms.

Authors:  Li Li; Haiyan Fu; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2022-07-04       Impact factor: 42.439

4.  Reactive Fibroblasts in Response to Optic Nerve Crush Injury.

Authors:  Xiangxiang Liu; Yuan Liu; Huiyi Jin; Mohamed M Khodeiry; Weizheng Kong; Ningli Wang; Jae K Lee; Richard K Lee
Journal:  Mol Neurobiol       Date:  2020-11-12       Impact factor: 5.590

Review 5.  Tissue-specific parameters for the design of ECM-mimetic biomaterials.

Authors:  Olivia R Tonti; Hannah Larson; Sarah N Lipp; Callan M Luetkemeyer; Megan Makam; Diego Vargas; Sean M Wilcox; Sarah Calve
Journal:  Acta Biomater       Date:  2021-04-18       Impact factor: 10.633

6.  Dissecting the Dual Role of the Glial Scar and Scar-Forming Astrocytes in Spinal Cord Injury.

Authors:  Tuo Yang; YuJuan Dai; Gang Chen; ShuSen Cui
Journal:  Front Cell Neurosci       Date:  2020-04-03       Impact factor: 5.505

7.  Microglial inflammation after chronic spinal cord injury is enhanced by reactive astrocytes via the fibronectin/β1 integrin pathway.

Authors:  Shingo Yoshizaki; Tetsuya Tamaru; Masamitsu Hara; Ken Kijima; Masatake Tanaka; Dai-Jiro Konno; Yoshihiro Matsumoto; Yasuharu Nakashima; Seiji Okada
Journal:  J Neuroinflammation       Date:  2021-01-06       Impact factor: 8.322

Review 8.  Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms.

Authors:  Anam Anjum; Muhammad Da'in Yazid; Muhammad Fauzi Daud; Jalilah Idris; Angela Min Hwei Ng; Amaramalar Selvi Naicker; Ohnmar Htwe Rashidah Ismail; Ramesh Kumar Athi Kumar; Yogeswaran Lokanathan
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 9.  Fibrosis in the central nervous system: from the meninges to the vasculature.

Authors:  Corey R Fehlberg; Jae K Lee
Journal:  Cell Tissue Res       Date:  2021-06-30       Impact factor: 5.249

10.  Pericytes: Problems and Promises for CNS Repair.

Authors:  Fabio Laredo; Julia Plebanski; Andrea Tedeschi
Journal:  Front Cell Neurosci       Date:  2019-12-06       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.